US Patent Application 20100063135 - POLYETHYLENE GLYCOL LIPID CONJUGATES AND USES THEREOF
Inventors
AssigneeUS Classes554/213, Additional oxygen in the acid moiety (e.g., hydroxystearic acid, etc.)554/103, Nitrogen containing554/79, Glycerophosphates (e.g., phosphatidic acids, phosphatidyl inositol, etc.)564/201, Hydroxy, bonded directly to carbon, or ether in substituent Q (H of -OH may be replaced by a substituted or unsubstituted ammonium ion or a Group IA or IIA light metal)536/23.1, DNA or RNA fragments or modified forms thereof (e.g., genes, etc.)530/402, Chemical modification or the reaction product thereof, e.g., covalent attachment or coupling, etc.514/182, Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system514/547, Compound contains two or more C(=O)O groups514/408The five-membered hetero ring consists of one nitrogen and four carbonsAttorney, Agent or FirmInternational ClassesA61K 31/7105C07C 229/00 C07F 9/02 C07C 233/01 C07H 21/02 C07K 17/00 A61K 31/56 A61K 31/225 A61K 31/40 Abstract textPolyethylene glycol (PEG)-lipid conjugates, polyethylene glycol (PEG)-lipid conjugate based drug delivery systems, ways to make them and methods of treating diseases using them are disclosed. |
| ||||||||||||||
